Crossmark

The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force

Crossref DOI link: https://doi.org/10.1186/s13023-019-1193-3

Published Online: 2019-10-15

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Southall, Noel T http://orcid.org/0000-0003-4500-880X
Natarajan, Madhusudan

Lau, Lilian Pek Lian

Jonker, Anneliene Hechtelt

Deprez, Benoît

Guilliams, Tim

Hunter, Lawrence

Rademaker, Carin MA

Hivert, Virginie

Ardigò, Diego
Funding

Funding for this research was provided by:

FP7 Research infrastructures (305207)
License Information

Text and Data Mining valid from 2019-10-15

Version of Record valid from 2019-10-15
More Information

Article History

Received: 12 April 2019

Accepted: 4 September 2019

First Online: 15 October 2019

Ethics approval and consent to participate

: Not applicable

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below